The hashtag “#BidenVaccine” trended on social media early Friday as President Donald Trump’s administration is preparing to clear the way for emergency distribution of the new COVID treatment developed under his “Operation Warp Speed” program.
At the same time, leftist users online tried to make the hashtag “#TrumpVirus” trend as well, despite the common knowledge COVID-19 originated in Wuhan Province, China.
— Suburban Woman 🌊🌊 There’s a meme for that! 🌊🌊 (@suburban_meme) December 4, 2020
It’s the Trump Virus.
And the #BidenVaccine.
— Scott Dworkin (@funder) December 4, 2020
— Julie B(rooklyn) 💙 (@althea89157) December 4, 2020
Blue Magas is what happened to @realDonaldTrump supporters when Joe Biden took Trump to the woodshed on Election Day. Trump failed so bad he couldn’t even win a second term! Sad #TrumpGOPDepression #TrumpDestroyedEconomy #BiggestLoser #TrumpVirus #BidenVaccine #OneTermTrump pic.twitter.com/U37n1BsjyS
— Deb Stein (@DebStein8) December 4, 2020
The false social media narratives come as the Food and Drug Administration prepares to grant two drugmakers — Pfizer and Moderna — emergency authorization to bring their COVID-19 vaccines to the public.
In an interview with ABC News earlier this week, FDA Commissioner Dr. Stephen Hahn said that his agency has “all hands on deck” and that personnel are “working day and night, and on the weekends” to both evaluate and clear vaccines for use and distribution.
Hahn said the agency’s scientists will ensure that “vigorous standards are being enforced when we look at safety and efficacy” of these vaccines. He added: ”We need to be able to make this assurance to the American people.”
Earlier, Hahn said, “We are committed to expediting the development of COVID-19 vaccines, but not at the expense of sound science and decision-making. We will not jeopardize the public’s trust in our science-based, independent review of these or any vaccines. There’s too much at stake.”
According to the FDA’s website, the agency’s Center for Biologics Evaluation and Research’s Vaccines and Related Biological Products Advisory Committee meets Dec. 10 to consider emergency approval of a vaccine jointly-developed by Pfizer and BioNTech for use in people over the age of 16.
A week later, on Dec. 17, the committee will meet to consider approval of Moderna’s vaccine, which would be administered to people 18 years or older.
Both vaccines must be stored in extremely cold conditions, and both must be administered in two doses, within 30 days’ time. The vaccines cannot be mixed.
Also, if a person receives the first dose but fails to get the second dose within the 30-day window, they have to begin the regimen anew, according to vaccine makers.
The development of a vaccine in record time and its pending approval and distribution to the public is the result of careful planning by the Trump campaign since the early months of the pandemic.
“Operation Warp Speed’s goal is to produce and deliver 300 million doses of safe and effective vaccines with the initial doses available by January 2021, as part of a broader strategy to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics,” Health and Human Services noted on its website announcing the Trump-directed initiative earlier this year.
HHS began handing out billions in funding to various pharmaceutical companies and vaccine research facilities in late March with “$456 million in funds for Johnson & Johnson’s (Janssen) candidate vaccine.”
At the same time, the Trump administration began developing a mass distribution plan that will involve the U.S. military.
“As part of Operation Warp Speed, we have been laying the groundwork for months to distribute and administer a safe and effective COVID-19 vaccine as soon as it meets FDA’s gold standard,” said HHS Secretary Alex Azar in mid-September.
“This in-depth, round-the-clock planning work with our state and local partners and trusted community organizations, especially through CDC, will ensure that Americans can receive a safe and effective vaccine in record time,” he added.
In an interview with Newsweek, an unnamed senior adviser to President Trump said he sees the rapid development of a COVID vaccine and its distribution as his “legacy,” adding the president isn’t going to letup despite his potential lame-duck status.
“He sees this as his legacy. He will absolutely push this until the last day,” the official said.
DONATE TO BIZPAC REVIEW
Please help us! If you are fed up with letting radical big tech execs, phony fact-checkers, tyrannical liberals and a lying mainstream media have unprecedented power over your news please consider making a donation to BPR to help us fight them. Now is the time. Truth has never been more critical!
- Jan. 6 committee chair Benny Thompson offers a stunning take on potential Trump criminal actions - January 2, 2022
- Life-long New Yorker posts ‘sad’ Twitter ode on post-pandemic Big Apple being ‘shadow of its former self’ - January 2, 2022
- NYPD officer shot in head in police lot as he slept in vehicle between shifts - January 2, 2022
We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please click the ∨ icon below and to the right of that comment. Thank you for partnering with us to maintain fruitful conversation.